Related Experiment Video
Updated: May 28, 2025

07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
15.6K
Isolated Pulmonary Valve Infective Endocarditis With Persistent Staphylococcus aureus Bacteremia and Rapid Clearance
Paulo Fernandes1, João Maia Oliveira1, Ana Rita Rocha2
1Intensive Care Unit, Hospital José Joaquim Fernandes, Beja, PRT.
Cureus
|February 12, 2025
Summary
This case study details a rare instance of isolated pulmonary valve infective endocarditis in a healthy man. A novel antibiotic combination of ertapenem and cefazolin successfully treated persistent Staphylococcus aureus bacteremia.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Infective endocarditis (IE) typically affects the heart's left side, with right-sided IE being less common.
- Isolated native pulmonary valve IE is exceptionally rare, posing diagnostic and therapeutic challenges.
- Staphylococcus aureus is a frequent causative agent of IE, often leading to severe complications.
Observation:
- A previously healthy 59-year-old man presented with non-specific symptoms and was diagnosed with isolated pulmonary valve IE.
- Initial transthoracic echocardiography did not reveal vegetations, complicating early diagnosis.
- The patient developed persistent Staphylococcus aureus bacteremia and septic shock despite standard antibiotic treatment.
Findings:
- Transesophageal echocardiography confirmed a large vegetation on the pulmonary valve, meeting Duke's criteria for definite IE.
- An unusual salvage antibiotic regimen combining ertapenem and cefazolin achieved rapid clearance of bacteremia.
- Surgical intervention with bioprosthetic pulmonary valve replacement was necessary for near-full recovery.
Implications:
- This case highlights the diagnostic difficulties of rare right-sided IE, especially with atypical presentations.
- The combination of ertapenem and cefazolin demonstrates potential efficacy in treating persistent Staphylococcus aureus bacteremia, possibly due to synergistic activity.
- Individualized management and further research are crucial for optimizing treatment strategies in severe and persistent IE cases.
Related Concept Videos
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pneumonia IV: Management
288
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
288

